Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newgen Biotech USA is a specialized manufacturer and distributor of enzymes, probiotics, and fermented functional ingredients serving the dietary supplement and food industries. As the North American subsidiary of Ningbo Newgen Biotech, the company leverages advanced microbial fermentation and purification technologies to produce high-potency ingredients such as nattokinase, serratiopeptidase, and vitamin K2 (MK-7). Their business model encompasses both the supply of standardized raw materials and the provision of custom formulation and contract manufacturing services. Newgen Biotech maintains a strong focus on quality control, operating under GMP standards to ensure the efficacy and safety of its biological products for global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newgen Biotech USA.